Table of Contents List of Tables List of Figures Introduction Global Markets Direct Report Coverage Fatigue - Overview Fatigue - Therapeutics Development Pipeline Overview Pipeline by Companies Products under Development by Companies Fatigue - Therapeutics Assessment Assessment by Target Assessment by Mechanism of Action Assessment by Route of Administration Assessment by Molecule Type Fatigue - Companies Involved in Therapeutics Development Aoxing Pharmaceutical Company Inc Chronos Therapeutics Ltd Helsinn Group K-Pax Pharmaceuticals Inc Merz Pharma GmbH & Co KgaA MultiCell Technologies Inc Resolys Bio Inc Fatigue - Drug Profiles (lofepramine hydrochloride + phenylalanine) - Drug Profile Product Description Mechanism Of Action R&D Progress anamorelin hydrochloride - Drug Profile Product Description Mechanism Of Action R&D Progress Biologic for Chronic Pain and Fatigue - Drug Profile Product Description Mechanism Of Action R&D Progress caffeine - Drug Profile Product Description Mechanism Of Action R&D Progress CTDP-001 - Drug Profile Product Description Mechanism Of Action R&D Progress KPAX-002 - Drug Profile Product Description Mechanism Of Action R&D Progress MRZ-9547 - Drug Profile Product Description Mechanism Of Action R&D Progress phenylbutyrate - Drug Profile Product Description Mechanism Of Action R&D Progress Fatigue - Dormant Projects Fatigue - Product Development Milestones Featured News & Press Releases Jun 14, 2010: MultiCell Retains CDSS To Manage MCT-125 Phase IIb Clinical Trial For PMSF In UK Appendix Methodology Coverage Secondary Research Primary Research Expert Panel Validation Contact Us Disclaimer

List of Tables Number of Products under Development for Fatigue, H1 2019 Number of Products under Development by Companies, H1 2019 Products under Development by Companies, H1 2019 Number of Products by Stage and Target, H1 2019 Number of Products by Stage and Mechanism of Action, H1 2019 Number of Products by Stage and Route of Administration, H1 2019 Number of Products by Stage and Molecule Type, H1 2019 Fatigue - Pipeline by Aoxing Pharmaceutical Company Inc, H1 2019 Fatigue - Pipeline by Chronos Therapeutics Ltd, H1 2019 Fatigue - Pipeline by Helsinn Group, H1 2019 Fatigue - Pipeline by K-Pax Pharmaceuticals Inc, H1 2019 Fatigue - Pipeline by Merz Pharma GmbH & Co KgaA, H1 2019 Fatigue - Pipeline by MultiCell Technologies Inc, H1 2019 Fatigue - Pipeline by Resolys Bio Inc, H1 2019 Fatigue - Dormant Projects, H1 2019List of Figures Number of Products under Development for Fatigue, H1 2019 Number of Products under Development by Companies, H1 2019 Number of Products by Targets, H1 2019 Number of Products by Stage and Targets, H1 2019 Number of Products by Mechanism of Actions, H1 2019 Number of Products by Stage and Mechanism of Actions, H1 2019 Number of Products by Top 10 Routes of Administration, H1 2019 Number of Products by Stage and Routes of Administration, H1 2019 Number of Products by Molecule Types, H1 2019 Number of Products by Stage and Molecule Types, H1 2019

Aoxing Pharmaceutical Company Inc Chronos Therapeutics Ltd Helsinn Group K-Pax Pharmaceuticals Inc Merz Pharma GmbH & Co KgaA MultiCell Technologies Inc Resolys Bio Inc